2015
DOI: 10.1002/rcs.1689
|View full text |Cite
|
Sign up to set email alerts
|

Transperitoneal robotic resection of benign primary retroperitoneal tumors: can it be widely used?

Abstract: Robot-assisted resection of benign retroperitoneal tumors is flexible and safe and provides better protection when complex lesions are removed. Copyright © 2015 John Wiley & Sons, Ltd.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

2
0
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 28 publications
2
0
0
1
Order By: Relevance
“…In general, the use of CLS or RALS in patients with retroperitoneal sarcomas is controversial, as most studies primarily focused on the prognosis of benign tumours undergoing minimally invasive operations. 19,20 In our study, the recurrence rate of malignant or borderline tumours was 38.5% (5/13), and the median PFS was 40.0 months, which was comparable to prior studies. 21,22 Similarly, Oh JK 23 performed a large retrospective study that involved 3432 patients with retroperitoneal sarcomas who underwent open surgery and 412 who underwent minimally invasive surgery, identifying comparable outcomes in overall survival between the two groups.…”
Section: Discussionsupporting
confidence: 88%
See 1 more Smart Citation
“…In general, the use of CLS or RALS in patients with retroperitoneal sarcomas is controversial, as most studies primarily focused on the prognosis of benign tumours undergoing minimally invasive operations. 19,20 In our study, the recurrence rate of malignant or borderline tumours was 38.5% (5/13), and the median PFS was 40.0 months, which was comparable to prior studies. 21,22 Similarly, Oh JK 23 performed a large retrospective study that involved 3432 patients with retroperitoneal sarcomas who underwent open surgery and 412 who underwent minimally invasive surgery, identifying comparable outcomes in overall survival between the two groups.…”
Section: Discussionsupporting
confidence: 88%
“…In general, the use of CLS or RALS in patients with retroperitoneal sarcomas is controversial, as most studies primarily focused on the prognosis of benign tumours undergoing minimally invasive operations 19,20 . In our study, the recurrence rate of malignant or borderline tumours was 38.5% (5/13), and the median PFS was 40.0 months, which was comparable to prior studies 21,22 .…”
Section: Discussionsupporting
confidence: 80%
“…Использование роботического комплекса дает хирургу ряд хорошо известных преимуществ: трехмерное изображение операционного поля, отсутствие эффекта преломления, 7 степеней свободы движения манипуляторов и т.д. Эти факторы обеспечивают высокий уровень удобства, безопасности, прецизионности и эргономичности при выполнении робот-ассистированных операций [18,[27][28][29][30][31][32][33]. В то же время при множественной локализации образований в раз-личных участках брюшной полости и забрюшинного пространства возникает необходимость в интраоперационной переустановке роботических портов, а также в смене расположения роботического комплекса, что значительно увеличивает длительность и трудоемкость оперативного вмешательства [27][28][29][30].…”
Section: Discussionunclassified